R&D returns are getting better, but not by much and not for everyone, report says – FierceBiotech
0
After three years of declining returns on R&D spend, the 12 largest operations have finally achieved an uptick in what they receive for each dollar of outlay. But the result is more of a bottoming out than a major turnaround, with returns still well below levels seen in 2010 and at least one company posting a negative yield.
Read more – FierceBiotech